نتایج جستجو برای: chemical inhibitors

تعداد نتایج: 557179  

2013
Wei Long Xiao-Dong Zhang Hong-Ying Wu Jin Jin Guang-Yun Yu Xin He Hao Wang Xiu Shen Ze-Wei Zhou Pei-Xun Liu Sai-Jun Fan

A traditional Chinese medicine (TCM) formula network including 362 TCM formulas was built by using complex network methodologies. The properties of this network were analyzed including network diameter, average distance, clustering coefficient, and average degree. Meanwhile, we built a TCM chemical space and a TCM metabolism room under the theory of chemical space. The properties of chemical sp...

پایان نامه :دانشگاه آزاد اسلامی - دانشگاه آزاد اسلامی واحد تهران مرکزی - دانشکده علوم پایه 1391

one of the applications of nanotechnology is use of carbon nanotubes for the targeted delivery of drug molecules. to demonstrate the physical and chemical properties of biomolecules and identify new material of drug properties, the interaction of carbon nanotubes (cnts) with biomolecules is a subject of many investigations. cnts is a synthetic compound with extraordinary mechanical, thermal, el...

2003
ANTHONY Y. H. LU REGINA W. WANG JIUNN H. LIN

Marker substrates, chemical inhibitors, and inhibitory antibodies are important tools for the identification of cytochrome P450 (P450) isoform responsible for the metabolism of therapeutic agents in vitro. In view of the versatile and nonspecific nature of P450 enzymes, many of the marker substrates and chemical inhibitors used for P450 in vitro reaction phenotyping are isoform selective but no...

2013
Lushan Yu Yan Jiang Lu Wang Rong Sheng Yongzhou Hu Su Zeng

BYZX, [(E)-2-(4-((diethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-one], belongs to a series of novel acetylcholinesterase inhibitors and has been synthesized as a new chemical entity for the treatment of Alzheimer's disease symptoms. When incubated with human liver microsomes (HLMs), BYZX was rapidly transformed into its metabolites M1, M2, and M3. The chemical structures of the...

Journal: :Molecules 2012
Yunfeng Tie Brooks McPhail Huixiao Hong Bruce A Pearce Laura K Schnackenberg Weigong Ge Dan A Buzatu Jon G Wilkes James C Fuscoe Weida Tong Bruce A Fowler Richard D Beger Eugene Demchuk

Polypharmacy increasingly has become a topic of public health concern, particularly as the U.S. population ages. Drug labels often contain insufficient information to enable the clinician to safely use multiple drugs. Because many of the drugs are bio-transformed by cytochrome P450 (CYP) enzymes, inhibition of CYP activity has long been associated with potentially adverse health effects. In an ...

2017
Alex G. Baldwin Jack Rivers-Auty Michael J.D. Daniels Claire S. White Carl H. Schwalbe Tom Schilling Halah Hammadi Panichakorn Jaiyong Nicholas G. Spencer Hazel England Nadia M. Luheshi Manikandan Kadirvel Catherine B. Lawrence Nancy J. Rothwell Michael K. Harte Richard A. Bryce Stuart M. Allan Claudia Eder Sally Freeman David Brough

NLRP3 is a receptor important for host responses to infection, yet is also known to contribute to devastating diseases such as Alzheimer's disease, diabetes, atherosclerosis, and others, making inhibitors for NLRP3 sought after. One of the inhibitors currently in use is 2-aminoethoxy diphenylborinate (2APB). Unfortunately, in addition to inhibiting NLRP3, 2APB also displays non-selective effect...

2014
Michael R McKeown Daniel L Shaw Harry Fu Shuai Liu Xiang Xu Jason J Marineau Yibo Huang Xiaofeng Zhang Dennis L Buckley Asha Kadam Zijuan Zhang Stephen C Blacklow Jun Qi Wei Zhang James E Bradner

BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer. Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function. Using fluorous-tagged multicomponent reactions, we developed a focused chemical library of bromodomain inhibito...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید